title: Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease.
abstract: We could identify the MPTP-like compound and isoquinoline derivative N-methyl-norsalsolinol (2-MDTIQ) in cerebrospinal fluid (CSF) of patients with Parkinson's disease. The presence of 2-MDTIQ negatively correlated with the disease duration. In order to study the relationship between presence of 2-MDTIQ and dopamine metabolism, we examined 3-O-methyl-dopa (MDOPA) and homovanillic acid (HVA) levels in CSF of 15 normal control subjects and 34 patients with Parkinson's disease (PD). In the PD group in which 2-MDTIQ was detected, the HVA/MDOPA ratio was also negatively correlated with the duration of the disease and was increased when compared to patients without 2-MDTIQ. Since in both PD groups the daily L-dopa dose, the mean MDOPA levels, and the daily L-dopa dose/MDOPA ratio were nearly identical the results are not related to different L-dopa medications. In vitro experiments demonstrated 2-MDTIQ to inhibit monoamine oxidase activity in the caudate-putamen. These results suggest that 2-MDTIQ indicates an increased dopamine turnover in patients with PD. The enhanced metabolism at the beginning of the disease is not due to the presence of 2-MDTIQ since it inhibits dopamine metabolism. Thus, 2-MDTIQ, probably endogenously synthesized from dopamine, appears as a result of a compensatively activated dopaminergic system.
authors.affiliation: Department of Neurology, Medical University of Lübeck, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Moser
authors.forename: J
authors.initials: J
authors.lastname: Scholz
authors.forename: F
authors.initials: F
authors.lastname: Nobbe
authors.forename: P
authors.initials: P
authors.lastname: Vieregge
authors.forename: V
authors.initials: V
authors.lastname: Böhme
authors.forename: H
authors.initials: H
authors.lastname: Bamberg
mesh_terms: D000328:Adult; D000368:Aged; D002556:Cerebrospinal Fluid Proteins; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D007546:Isoquinolines / Q000134:cerebrospinal fluid*; D008297:Male; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000378:metabolism; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000201:enzymology; D044005:Tetrahydroisoquinolines; D014443:Tyrosine / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid
chemical_list: D002556:Cerebrospinal Fluid Proteins; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; C069194:2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline; D014443:Tyrosine; D008995:Monoamine Oxidase; C008404:3-methoxytyrosine; D004298:Dopamine; D006719:Homovanillic Acid